| CD44 | Cluster of Differentiation 44 |
| CD133 | Cluster of Differentiation 133 |
| CGGA | Chinese Glioma Genome Atlas |
| CISH | Chromogenic In Situ Hybridization |
| CNS | Central Nervous System |
| EGFR | Epidermal Growth Factor Receptor |
| FISH | Fluorescence In Situ Hybridization |
| GBM | Glioblastoma |
| GSC | Glioma Stem Cells |
| HDMT | Histone Deacetylase |
| ICER | Incremental Cost-Effectiveness Ratio |
| IDH | Isocitrate Dehydrogenase |
| KDMT | Histone Demethylates |
| LGG | Low-Grade Glioma |
| LYG | Life Years Gained |
| MAPK | Mitogen Activated Protein Kinases |
| MGMT | O6-methylguanine-DNA Methyltransferase |
| MLPA | Multiplex Ligation-Dependent Probe Amplification |
| MRI | Magnetic Resonance Imaging |
| NF1 | Neurofibromatosis 1 |
| NGS | Next-Generation Sequencing |
| NHS | National Health Service |
| PDFRA | Platelet-Derived Growth Factors |
| PTEN | Phosphatase and Tensin Homolog |
| P13K-AKT | Phosphoinositide 3-kinasem-Protein Kinase B |
| QALY | Quality-Adjusted Life Years 18-FET-PET |
| RPA | Recursive Partitioning Analysis |
| RT | Radiation therapy |
| SEER | Surveillance, Epidemiology, and End Results |
| TAZ | WW Domain-Containing Transcriptional Regulator 1 |
| TCGA | The Cancer Genome Atlas |
| TERT | Telomerase Reverse Transcriptase |
| TMB | Tumor Mutation Burden Testing |
| TMZ | Temozolomide |
| TP53 | Tumor Protein p53 |
| YAP | Yes-Associated Protein |
| VEGF | Vascular Endothelial Growth Factor |
| 18F-FET PET | O-(2-[18F]fluoroethyl)-L-tyrosine Positron Emission Tomography |